TMEM110-RFT1 Fusion FISH Probe
The TMEM110-RFT1 Fusion FISH Probe is used to confirm a fusion of the TMEM110 and RFT1 genes. The fusion of the TMEM110 and RFT1 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TMEM110-RFT1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TMEM110-RFT1-20-AQAQ | 20 (40 μL) | 200 μL |
|
RFT1 Gene Summary
This gene encodes an enzyme which catalyzes the translocation of the Man(5)GlcNAc (2)-PP-Dol intermediate from the cytoplasmic to the luminal side of the endoplasmic reticulum membrane in the pathway for the N-glycosylation of proteins. Mutations in this gene are associated with congenital disorder of glycosylation type In.[provided by RefSeq, Dec 2008]
Gene Name: RFT1 Homolog
Chromosome: CHR3: 53122500 -53164470
Locus: 3p21.1
Gene Diseases
The TMEM110 RFT1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|